Foldax Inc. was recently highlighted among a select group of companies shaping the next generation of heart valve replacement....
Read moreSivers Semiconductors is supplying lasers and optical amplifiers to a strategic LiDAR customer, with production expected to ramp in...
Read moreActuate Therapeutics announced clinical trial results published in Nature Medicine showing that adding elraglusib to chemotherapy doubled 12-month survival rates in patients with...
Read moreHypersonic design used to take years — now we’re seeing dramatically shorter timelines. Aerospace firms like Specter Aerospace are...
Read moreSivers Semiconductors has announced the availability of its Daybreak 5G/6G beamforming ICs designed for emerging FR3 applications, a frequency...
Read moreProvivi is expanding its reach in Europe through a new distribution agreement with Andermatt Group focused on sustainable crop...
Read moreSivers Semiconductors has partnered with O-Net and Enablence Technologies to develop external light sources for next-generation AI data centers....
Read moreActuate Therapeutics has launched a new strategic research initiative exploring combination therapies with its lead drug, elraglusib. Read more...
Read moreSivers Semiconductors announced that a strategic LiDAR customer has incorporated its photonics technology across their sensing platforms and plans...
Read moreActuate Therapeutics will be presenting at the upcoming Citizens Life Sciences Conference on March 10, with CEO Dan Schmitt....
Read more